ArQule, Inc. (ARQL) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
ONE WALL STREET BURLINGTON, MA 01803 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | 6/30/2018 Q2 | 3/31/2018 Q1 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 179,121 | 92,223 | 99,558 | 100,181 | 46,075 | 42,884 | |||
| Cash and cash equivalents | 108,685 | 17,824 | 19,236 | 16,178 | 16,917 | 10,537 | |||
| Short-term investments | 70,436 | 74,399 | 80,322 | 84,003 | 29,158 | 32,347 | |||
| Receivables | 1,450 | 3,300 | 5,984 | 6,401 | 3,187 | 1,200 | |||
| Prepaid expense | 1,428 | 1,367 | 861 | 776 | 625 | ||||
| Other undisclosed current assets | 713 | ||||||||
| Total current assets: | 181,999 | 96,890 | 106,403 | 107,358 | 49,887 | 44,797 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 455 | 339 | 69 | 80 | 90 | 102 | |||
| Long-term investments and receivables | 3,638 | 4,907 | |||||||
| Long-term investments | 3,638 | 4,907 | |||||||
| Other noncurrent assets | 249 | 248 | 204 | 204 | 204 | 204 | |||
| Other undisclosed noncurrent assets | 852 | 996 | |||||||
| Total noncurrent assets: | 5,194 | 1,583 | 273 | 5,191 | 294 | 306 | |||
| TOTAL ASSETS: | 187,193 | 98,473 | 106,676 | 112,549 | 50,181 | 45,103 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 9,795 | 11,541 | 12,948 | 10,771 | 8,336 | 8,269 | |||
| Employee-related liabilities | 1,686 | 1,221 | 1,971 | 1,589 | 1,415 | 793 | |||
| Accounts payable | 983 | 981 | 1,329 | 1,071 | 186 | 396 | |||
| Accrued liabilities | 1,176 | 1,070 | 1,151 | 1,266 | 971 | 1,041 | |||
| Other undisclosed accounts payable and accrued liabilities | 5,950 | 8,269 | 8,497 | 6,845 | 5,764 | 6,039 | |||
| Debt | 4,166 | 2,917 | 1,667 | 417 | |||||
| Other undisclosed current liabilities | 552 | 562 | |||||||
| Total current liabilities: | 14,513 | 15,020 | 14,615 | 11,188 | 8,336 | 8,269 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 10,753 | 11,923 | 13,093 | 14,264 | 14,601 | 14,517 | |||
| Long-term debt, excluding current maturities | 10,753 | 11,923 | 13,093 | 14,264 | 14,601 | 14,517 | |||
| Liabilities, other than long-term debt | 3,782 | ||||||||
| Operating lease, liability | ✕ | ✕ | ✕ | ✕ | |||||
| Derivative instruments and hedges, liabilities | 3,782 | ||||||||
| Other undisclosed noncurrent liabilities | 311 | 444 | |||||||
| Total noncurrent liabilities: | 11,064 | 12,367 | 13,093 | 14,264 | 14,601 | 18,299 | |||
| Total liabilities: | 25,577 | 27,387 | 27,708 | 25,452 | 22,937 | 26,568 | |||
| Temporary equity, carrying amount | 8,843 | ||||||||
| Equity | |||||||||
| Equity, attributable to parent | 161,616 | 71,086 | 78,968 | 87,097 | 27,244 | 9,692 | |||
| Common stock | 1,203 | 1,091 | 1,090 | 1,090 | 961 | 871 | |||
| Additional paid in capital | 727,712 | 628,260 | 625,993 | 625,572 | 560,219 | 547,932 | |||
| Accumulated other comprehensive income (loss) | 80 | 22 | (95) | (32) | (22) | (41) | |||
| Accumulated deficit | (567,379) | (558,287) | (548,020) | (539,533) | (533,914) | (539,070) | |||
| Total equity: | 161,616 | 71,086 | 78,968 | 87,097 | 27,244 | 9,692 | |||
| TOTAL LIABILITIES AND EQUITY: | 187,193 | 98,473 | 106,676 | 112,549 | 50,181 | 45,103 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | 6/30/2018 Q2 | 3/31/2018 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 281 | 1,345 | (22,823) | 4,979 | 13,706 | |||
| Gross profit: | 281 | 1,345 | 4,979 | 13,706 | ||||
| Operating expenses | (9,498) | (11,748) | (11,589) | (10,690) | (9,021) | (8,163) | ||
| Other undisclosed operating income | 2,941 | 4,138 | ||||||
| Operating income (loss): | (9,217) | (10,403) | (8,648) | (5,711) | 4,685 | (4,025) | ||
| Nonoperating income (expense) | 558 | 566 | 514 | 718 | (2,270) | |||
| Investment income, nonoperating | 558 | 566 | 514 | 170 | 159 | |||
| Interest and debt expense | (433) | (430) | (431) | (422) | (417) | (396) | ||
| Income (loss) from continuing operations before equity method investments, income taxes: | (9,092) | (10,267) | (9,079) | (5,619) | 4,986 | (6,691) | ||
| Other undisclosed income from continuing operations before income taxes | 1,435 | |||||||
| Income (loss) from continuing operations: | (9,092) | (10,267) | (7,644) | (5,619) | 4,986 | (6,691) | ||
| Income (loss) before gain (loss) on sale of properties: | (9,092) | (10,267) | (7,644) | (5,619) | 4,986 | (6,691) | ||
| Net income (loss): | (9,092) | (10,267) | (7,644) | (5,619) | 4,986 | (6,691) | ||
| Other undisclosed net income (loss) attributable to parent | (843) | 170 | 159 | |||||
| Net income (loss) available to common stockholders, diluted: | (9,092) | (10,267) | (8,487) | (5,619) | 5,156 | (6,532) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | 6/30/2018 Q2 | 3/31/2018 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (9,092) | (10,267) | (7,644) | (5,619) | 4,986 | (6,691) | ||
| Comprehensive income (loss): | (9,092) | (10,267) | (7,644) | (5,619) | 4,986 | (6,691) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 58 | 117 | (906) | (10) | 189 | 134 | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (9,034) | (10,150) | (8,550) | (5,629) | 5,175 | (6,557) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.